drugset / Trial / NCT01028040

AZD Single Ascending Dose Study In Healthy Japanese Subjects

NCT01028040 ↗

Phase 1 Completed 72 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is a single centre, open label, non-randomised study to access the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD3043 following a single dose administration to Japanese subjects.

Timeline

Start
2009-12
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD3043 Small molecule — Intravenous

Indications

No indication recorded.